المؤلفون: Trevarrow MP; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA., Munoz MJ; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA., Rivera YM; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA., Arora R; Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Drane QH; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA., Pal GD; Division of Movement Disorders, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Verhagen Metman L; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Goelz LC; Department of Kinesiology and Nutrition, UIC College of Applied Health Sciences, Chicago, Illinois, USA., Corcos DM; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA.; McCormick School of Engineering, Northwestern University, Evanston, Illinois, USA., David FJ; Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, Illinois, USA.

المصدر: Physiological reports [Physiol Rep] 2024 Sep; Vol. 12 (17), pp. e16150.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM ID: 101607800 Publication Model: Print Cited Medium: Internet ISSN: 2051-817X (Electronic) Linking ISSN: 2051817X NLM ISO Abbreviation: Physiol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/drug therapy , Parkinson Disease*/physiopathology , Antiparkinson Agents*/therapeutic use , Antiparkinson Agents*/administration & dosage , Reaction Time*/drug effects , Psychomotor Performance*/drug effects, Humans ; Male ; Female ; Aged ; Middle Aged ; Movement ; Memory/drug effects

المؤلفون: Abu-Hassan AA; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt., Mahdi WA; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Alshehri S; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., El Hamd MA; Department of Pharmaceutical Chemistry, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, Egypt.

المصدر: Luminescence : the journal of biological and chemical luminescence [Luminescence] 2024 Aug; Vol. 39 (8), pp. e4853.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley & Sons Country of Publication: England NLM ID: 100889025 Publication Model: Print Cited Medium: Internet ISSN: 1522-7243 (Electronic) Linking ISSN: 15227235 NLM ISO Abbreviation: Luminescence Subsets: MEDLINE

مواضيع طبية MeSH: Indans*/chemistry , Indans*/analysis , Tablets* , Antiparkinson Agents*/analysis , Antiparkinson Agents*/chemistry, Limit of Detection ; Molecular Structure ; Fluorescent Dyes/chemistry ; Spectrometry, Fluorescence

المؤلفون: Barer Y; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Ha'Mered 27, 6812509, Tel Aviv, Israel. barer_y@mac.org.il., Sánchez-Soliño O; AbbVie Inc., North Chicago, IL, USA., Chodick G; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Ha'Mered 27, 6812509, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Grabarnik-John M; AbbVie Inc., Hod Hasharon, Israel., Blonder SN; AbbVie Inc., Hod Hasharon, Israel., Feurestein-Ganor NL; AbbVie Inc., Hod Hasharon, Israel., Bergmann L; AbbVie Inc., North Chicago, IL, USA., Yan CH; AbbVie Inc., North Chicago, IL, USA., Gazit S; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Ha'Mered 27, 6812509, Tel Aviv, Israel., Arkadir D; Department of Neurology and the Faculty of Medicine, Hadassah Medical Center, The Hebrew University, Jerusalem, Israel.

المصدر: Advances in therapy [Adv Ther] 2024 Aug; Vol. 41 (8), pp. 3419-3425. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/drug therapy , Parkinson Disease*/mortality , Antiparkinson Agents*/therapeutic use , Antiparkinson Agents*/administration & dosage , Levodopa*/therapeutic use , Levodopa*/administration & dosage, Humans ; Male ; Female ; Aged ; Retrospective Studies ; Middle Aged ; Dose-Response Relationship, Drug ; Risk Factors ; Aged, 80 and over

المؤلفون: Dean MN; Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Standaert DG

المصدر: Current opinion in neurology [Curr Opin Neurol] 2024 Aug 01; Vol. 37 (4), pp. 409-413. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9319162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-6551 (Electronic) Linking ISSN: 13507540 NLM ISO Abbreviation: Curr Opin Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Levodopa*/therapeutic use , Parkinson Disease*/drug therapy , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/therapeutic use , Carbidopa*/administration & dosage , Carbidopa*/therapeutic use, Humans ; Drug Combinations ; Infusions, Subcutaneous/methods

المؤلفون: Hamed SA; Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, Egypt., Hadad AFE; Department of Neurology and Psychiatry, Al Azhar University Hospital, Assiut, Egypt.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 Aug; Vol. 17 (8), pp. 743-753. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/drug therapy , Parkinson Disease*/physiopathology , Cholinergic Antagonists*/administration & dosage , Cholinergic Antagonists*/adverse effects , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/pharmacology , Antiparkinson Agents*/adverse effects , Cognitive Dysfunction*/etiology , Cognitive Dysfunction*/drug therapy, Humans ; Male ; Middle Aged ; Female ; Cohort Studies ; Egypt ; Aged ; Case-Control Studies ; Levodopa/administration & dosage ; Levodopa/pharmacology ; Levodopa/adverse effects ; Adult ; Amantadine/administration & dosage ; Amantadine/pharmacology ; Amantadine/adverse effects ; Carbidopa/administration & dosage ; Carbidopa/pharmacology ; Carbidopa/adverse effects ; Neuropsychological Tests ; Drug Combinations ; Depression/drug therapy ; Depression/epidemiology ; Benztropine/pharmacology ; Benztropine/administration & dosage ; Benztropine/adverse effects ; Cognition/drug effects ; Dopamine Agents/administration & dosage ; Dopamine Agents/pharmacology ; Dopamine Agents/adverse effects

المؤلفون: Rodríguez-Violante M; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.; Movement Disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico., Hernández-Medrano AJ; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Mexico City, Mexico., Cervantes-Arriaga A; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Mexico City, Mexico., Torres-Vásquez C; Department of Neurology, Pontificia Universidad Católica Madre y Maestra, Santo Domingo, Dominican Republic., Tristán-Samaniego D; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Mexico City, Mexico., Zepeda-Salazar C; Movement Disorders Clinic, Rosales National Hospital, San Salvador, El Salvador., Cerino-Palomino V; Department of Neurology, Hospital Ángeles Villahermosa, Villahermosa, Tabasco, Mexico., Abundes-Corona A; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

المصدر: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion [Rev Invest Clin] 2024 Jul 17; Vol. 76 (3), pp. 133-144. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Journal Article; Review; Comparative Study

بيانات الدورية: Publisher: Permanyer Country of Publication: Mexico NLM ID: 9421552 Publication Model: Electronic Cited Medium: Internet ISSN: 0034-8376 (Print) Linking ISSN: 00348376 NLM ISO Abbreviation: Rev Invest Clin Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/administration & dosage , Levodopa*/therapeutic use , Levodopa*/adverse effects , Parkinson Disease*/drug therapy , Antiparkinson Agents*/therapeutic use , Antiparkinson Agents*/pharmacology , Antiparkinson Agents*/administration & dosage , Dopamine Agonists*/therapeutic use , Dopamine Agonists*/administration & dosage, Humans ; Severity of Illness Index

المؤلفون: Ibrahim EA; Pharmaceutical Analytical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City, Giza, Egypt., Marzouk HM; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr Al-Aini Street, Cairo, 11562, Egypt. hodaallah.marzouk@pharma.cu.edu.eg., Hegazy MA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Cairo, 11835, Egypt., Fattah LEA; Pharmaceutical Analytical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City, Giza, Egypt., Saad SS; Pharmaceutical Analytical Chemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, 6th of October City, Giza, Egypt.

المصدر: Scientific reports [Sci Rep] 2024 Jul 16; Vol. 14 (1), pp. 16460. Date of Electronic Publication: 2024 Jul 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Micelles* , Spectrometry, Fluorescence*/methods , Alanine*/analogs & derivatives , Alanine*/blood , Antiparkinson Agents*/blood , Antiparkinson Agents*/analysis , Antiparkinson Agents*/therapeutic use , Benzylamines*/blood , Benzylamines*/analysis , Benzylamines*/chemistry, Humans ; Tablets ; Limit of Detection ; Reproducibility of Results

المؤلفون: Yuksel JM; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Ulen KR; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Brenner JM; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York., Brangman SA; 2 Upstate University Hospital, 750 East Adam Street, Syracuse, New York., Noviasky J; 1 Upstate Community Hospital, 4900 Broad Road, Syracuse, New York.

المصدر: The Senior care pharmacist [Sr Care Pharm] 2024 Jul 01; Vol. 39 (7), pp. 242-248.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Consultant Pharmacists Country of Publication: United States NLM ID: 101737969 Publication Model: Print Cited Medium: Print ISSN: 2639-9636 (Print) Linking ISSN: 26399636 NLM ISO Abbreviation: Sr Care Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Carbidopa*/administration & dosage , Carbidopa*/therapeutic use , Levodopa*/administration & dosage , Levodopa*/therapeutic use , Parkinson Disease*/drug therapy , Emergency Service, Hospital*/statistics & numerical data , Drug Combinations* , Length of Stay* , Antiparkinson Agents*/administration & dosage , Antiparkinson Agents*/therapeutic use, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Aged, 80 and over ; Treatment Outcome ; Patient Readmission/statistics & numerical data

المؤلفون: Barbosa R; Neurology Deparment, Centre Hospitalier Universitaire Toulouse, Toulouse, France.; Nova Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa, Lisbon, Portugal., Mendonça M; Nova Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa, Lisbon, Portugal.; Champalimaud Research and Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal., Bastos P; Neurology Deparment, Centre Hospitalier Universitaire Toulouse, Toulouse, France.; Nova Medical School, Faculdade de Ciências Medicas, Universidade Nova de Lisboa, Lisbon, Portugal., Pita Lobo P; Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Valadas A; Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Correia Guedes L; Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Ferreira JJ; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; CNS- Campus Neurológico Senior, Torres Vedras, Portugal., Rosa MM; Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Matias R; Physics Department & Institute of Biophysics and Biomedical Engineering (IBEB), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.; Kinetikos, Coimbra, Portugal., Coelho M; Department of Neurosciences and Mental Health, Neurology Hospital Santa Maria, CHLUN, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

المصدر: Movement disorders clinical practice [Mov Disord Clin Pract] 2024 Jul; Vol. 11 (7), pp. 795-807. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2330-1619 (Electronic) Linking ISSN: 23301619 NLM ISO Abbreviation: Mov Disord Clin Pract Subsets: MEDLINE

مواضيع طبية MeSH: Levodopa*/therapeutic use , Levodopa*/administration & dosage , Parkinson Disease*/drug therapy , Parkinson Disease*/physiopathology , Antiparkinson Agents*/therapeutic use , Antiparkinson Agents*/administration & dosage , Gait*/drug effects, Humans ; Male ; Biomechanical Phenomena ; Female ; Aged ; Middle Aged ; Gait Disorders, Neurologic/physiopathology ; Gait Disorders, Neurologic/drug therapy ; Gait Disorders, Neurologic/diagnosis ; Gait Disorders, Neurologic/etiology ; Severity of Illness Index

المؤلفون: Theyer C; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Beliveau V; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Krismer F; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Peball M; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Mair K; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Heim B; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Djamshidian A; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Kiechl S; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Eisner W; Department of Neurosurgery, Innsbruck Medical University, Innsbruck, Austria., Eschlböck S; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Wenning GK; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Willeit P; Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria.; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Seppi K; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Poewe W; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria., Mahlknecht P; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

المصدر: Movement disorders clinical practice [Mov Disord Clin Pract] 2024 Jul; Vol. 11 (7), pp. 855-860. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101630279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2330-1619 (Electronic) Linking ISSN: 23301619 NLM ISO Abbreviation: Mov Disord Clin Pract Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/therapy , Parkinson Disease*/drug therapy , Deep Brain Stimulation*/methods , Subthalamic Nucleus* , Antiparkinson Agents*/therapeutic use , Antiparkinson Agents*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Levodopa/administration & dosage ; Levodopa/therapeutic use ; Longitudinal Studies ; Treatment Outcome